Changes in serum alkaline phosphatase after femoral fractures.
Osteomalacia may be a contributory factor in some patients in the development of fractures of the femoral neck and complicate the subsequent management. The level of serum alkaline phosphatase is often valuable in the diagnosis of metabolic bone disease but rises after any uncomplicated fracture, and since such a rise may limit the diagnostic usefulness of this measurement in detecting osteomalacia its extent was assessed in 106 patients. In the majority serum levels were normal on admission, rising after seven to nine days to reach a maximum within a month after fracture. Elevated levels on admission were found in patients with osteomalacia, liver damage or where there had been a delay of several weeks between injury and admission. In a small number of patients normal levels on admission subsequently reached very high values, usually in association with comminution or instability of the fracture. Elevated levels persisted for six to twelve weeks after fracture, the major influence upon the level at this time being the maximum value achieved rather than the presence of osteomalacia. If patients are to be screened for osteomalacia, the alkaline phosphatase must be measured within the first week after a fracture to avoid the distorting influences of the fracture itself.
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood*; D005260:Female; D005265:Femoral Neck Fractures / Q000201:enzymology* / Q000209:etiology; D006620:Hip Fractures / Q000201:enzymology* / Q000209:etiology; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000150:complications* / Q000201:enzymology
D000469:Alkaline Phosphatase